FR2231388B1 - - Google Patents

Info

Publication number
FR2231388B1
FR2231388B1 FR7418862A FR7418862A FR2231388B1 FR 2231388 B1 FR2231388 B1 FR 2231388B1 FR 7418862 A FR7418862 A FR 7418862A FR 7418862 A FR7418862 A FR 7418862A FR 2231388 B1 FR2231388 B1 FR 2231388B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7418862A
Other languages
French (fr)
Other versions
FR2231388A1 (ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Asahi Chemical Industry Co Ltd
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Publication of FR2231388A1 publication Critical patent/FR2231388A1/fr
Application granted granted Critical
Publication of FR2231388B1 publication Critical patent/FR2231388B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
FR7418862A 1973-05-30 1974-05-30 Expired FR2231388B1 (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5970973A JPS535678B2 (ko) 1973-05-30 1973-05-30

Publications (2)

Publication Number Publication Date
FR2231388A1 FR2231388A1 (ko) 1974-12-27
FR2231388B1 true FR2231388B1 (ko) 1977-11-04

Family

ID=13120999

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7418862A Expired FR2231388B1 (ko) 1973-05-30 1974-05-30

Country Status (6)

Country Link
JP (1) JPS535678B2 (ko)
CH (1) CH582695A5 (ko)
DE (1) DE2426304A1 (ko)
FR (1) FR2231388B1 (ko)
GB (1) GB1449708A (ko)
HU (1) HU170244B (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2614946C2 (de) * 1975-04-08 1987-04-23 Asahi Kasei Kogyo K.K., Osaka Neue Nucleosidderivate
JPS51143683A (en) * 1975-06-06 1976-12-10 Yamasa Shoyu Co Ltd A process for preparing n4- acylarabinofuranosyl cytosines
JPS5840528B2 (ja) * 1975-12-31 1983-09-06 旭化成株式会社 Ｎ４− ベヘノイルシトシンアラビノシドノスイヨウカホウホウ
JPS552602A (en) * 1978-06-20 1980-01-10 Yamasa Shoyu Co Ltd 1-beta-d-arabinofranosylcytosine-5'-phosphoric acid oleyl ester
JPS5622724A (en) * 1979-08-02 1981-03-03 Asahi Chem Ind Co Ltd Pharmaceutical preparation of n4-acylcytosine arabinoside
DE3323621A1 (de) * 1982-07-08 1984-03-01 Yamasa Shoyu K.K., Choshi, Chiba Pharmazeutisches praeparat mit die antitumor-wirkung verstaerkender wirkung, ein solches praeparat enthaltende chemotherapeutische zusammensetzung und verwendung des praeparates zur unterstuetzung der antitumor-behandlung beim menschen und tier
JPS5925327A (ja) * 1982-07-31 1984-02-09 Hidematsu Hirai 抗腫瘍性複合体の製造方法
JPS6330879Y2 (ko) * 1985-08-30 1988-08-17
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
CL2009002206A1 (es) 2008-12-23 2011-08-26 Gilead Pharmasset Llc Compuestos derivados de pirrolo -(2-3-d]-pirimidin-7(6h)-tetrahidrofuran-2-il fosfonamidato, composicion farmaceutica; y su uso en el tratamiento de enfermedades virales.
NZ593648A (en) 2008-12-23 2013-09-27 Gilead Pharmasset Llc Nucleoside phosphoramidates
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
KR101715981B1 (ko) 2010-03-31 2017-03-13 길리애드 파마셋 엘엘씨 뉴클레오사이드 포스포르아미데이트
EP3453386A1 (en) * 2017-09-08 2019-03-13 Universite D'angers Nanocapsules comprising modified nucleobases and/or nucleosides, hydrogels and oleogels comprising them and uses thereof
CN108727449A (zh) * 2018-04-25 2018-11-02 山东大学 一种新型阿糖胞苷前药MA-Ara纳米组装体的制备方法及应用
CN108409819A (zh) * 2018-04-25 2018-08-17 山东大学 一种新型阿糖胞苷前药DA-Ara纳米组装体的制备方法及应用
CN108610384B (zh) * 2018-05-31 2022-02-22 沈阳药科大学 基于肠道mct1载体蛋白设计的前药及其制备方法

Also Published As

Publication number Publication date
DE2426304C2 (ko) 1988-03-17
CH582695A5 (ko) 1976-12-15
FR2231388A1 (ko) 1974-12-27
GB1449708A (en) 1976-09-15
DE2426304A1 (de) 1975-01-02
JPS5018482A (ko) 1975-02-26
JPS535678B2 (ko) 1978-03-01
HU170244B (ko) 1977-05-28

Similar Documents

Publication Publication Date Title
AR201758A1 (ko)
AU476761B2 (ko)
AR201235Q (ko)
AR201231Q (ko)
AU471343B2 (ko)
FR2231388B1 (ko)
AU465453B2 (ko)
AU450229B2 (ko)
AR201229Q (ko)
AU466283B2 (ko)
AU472848B2 (ko)
AU447540B2 (ko)
AR200885A1 (ko)
AR201432A1 (ko)
AR196382A1 (ko)
AR197627A1 (ko)
AU471461B2 (ko)
AU461342B2 (ko)
AR210729A1 (ko)
AR200256A1 (ko)
AR196212Q (ko)
AR196123Q (ko)
AU1891376A (ko)
CH562060A5 (ko)
BG19482A1 (ko)

Legal Events

Date Code Title Description
ST Notification of lapse